Selene S. Mak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Selene S. Mak has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
- Garrett I. Ash
School of Medicine Yale University New Haven Connecticut USA
11 shared publications - Constance H. Fung
VA Greater Los Angeles Healthcare System, North Hills, United States
8 shared publications Erin Der-McLeod
4 shared publicationsPaul G. Shekelle
Veterans Health Administration, Greater Los Angeles Healthcare System, Los Angeles, USA
4 shared publications- Li-Jung Liang
Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles , Los Angeles, CA
3 shared publications - Sara Ghadimi
Geriatric Research, Education, and Clinical Center, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA
3 shared publications
Latest Publications
- 1 September 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Eliciting participant perspectives about a mailed brochure on sleeping pills and cognitive behavioural therapy for insomnia to inform future implementation of deprescribing interventions
Objectives: To explore how older adults engaged with a direct-to-patient brochure and telephone reinforcement call about benzodiazepine receptor agonist (BZRA) risks and discontinuation, including barriers and facilitators to acting on brochure content. Methods: This qualitative analysis was conducted within a 3-arm pilot randomized trial at 2 Veterans Health Administration facilities. Participants randomized to the active brochure plus telephone reinforcement call arm (n = 120) were contacted up to two times. Field notes from completed calls were analysed using qualitative content analysis. Key findings: Seventy-two participants completed a call. Three themes emerged: brochure awareness and interest, intention to act on brochure content, and perceptions of insomnia and BZRAs. Participants varied in whether they recalled or reviewed the brochure, whether they planned to discuss BZRA use with a clinician or use digital cognitive behavioural therapy for insomnia, and how they understood long-term BZRA use. Conclusions: Limited recall of mailed materials, digital access barriers, and beliefs about BZRA use may shape engagement with low-touch deprescribing interventions.
- 1 September 2026
- Published by Oxford University Press (OUP) in International Journal of Pharmacy Practice
Eliciting participant perspectives about a mailed brochure on sleeping pills and cognitive behavioural therapy for insomnia to inform future implementation of deprescribing interventions
Objectives: To explore how older adults engaged with a direct-to-patient brochure and telephone reinforcement call about benzodiazepine receptor agonist (BZRA) risks and discontinuation, including barriers and facilitators to acting on brochure content. Methods: This qualitative analysis was conducted within a 3-arm pilot randomized trial at 2 Veterans Health Administration facilities. Participants randomized to the active brochure plus telephone reinforcement call arm (n = 120) were contacted up to two times. Field notes from completed calls were analysed using qualitative content analysis. Key findings: Seventy-two participants completed a call. Three themes emerged: brochure awareness and interest, intention to act on brochure content, and perceptions of insomnia and BZRAs. Participants varied in whether they recalled or reviewed the brochure, whether they planned to discuss BZRA use with a clinician or use digital cognitive behavioural therapy for insomnia, and how they understood long-term BZRA use. Conclusions: Limited recall of mailed materials, digital access barriers, and beliefs about BZRA use may shape engagement with low-touch deprescribing interventions.
- Open Access
- 20 August 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 26 (1)
Use of massage therapy for non-painful health conditions: an evidence map of systematic reviews
Background: There is high- or moderate-certainty evidence that massage therapy is beneficial for certain painful conditions. Massage therapy has also been evaluated for a range of non-painful health conditions, but the extent and certainty of this evidence are less well characterized. We mapped the systematic reviews, conclusions, and certainty (quality or strength) of evidence for outcomes of massage therapy for non-painful health conditions. Methods: Computerized search of PubMed, AMED, CINAHL, Cochrane Database of Systematic Reviews, and Web of Science from July 2018 to July 2024. This evidence map updates a Department of Veterans Affairs (VA) report that covered massage therapy reviews published through July 2018. Study selection included systematic reviews of massage therapy for non-painful adult health conditions that formally rated the certainty (quality or strength) of evidence supporting the conclusions. Systematic reviews of sports massage therapy, osteopathy, dry cupping/dry needling, and internal massage therapy (e.g., for pelvic floor pain), and self-administered massage therapy techniques (e.g., foam rolling) were ineligible. Main outcomes and measures include health condition, number of included studies, intervention, comparison group, conclusions, and certainty of evidence. Results: A total of 13 systematic reviews of massage therapy for 8 non-painful adult health conditions were identified. Of 190 full-text reviews, 20 used a formal method to rate the certainty (quality or strength) of evidence supporting their conclusions; 7 reviews overlapped in health condition, resulting in 13 included reviews. Across these, one conclusion about abdominal massage therapy for functional constipation was rated as high certainty of evidence. There were 4 conclusions from 3 reviews rated as moderate certainty of evidence: 2 conclusions in 1 review about acupressure and auricular acupressure for improving sleep quality in patients with cancer, 1 conclusion about acupressure for sleep latency and fatigue in people with chronic kidney disease, and 1 conclusion about massage improving depressive symptoms in individuals living with dementia; all remaining conclusions were rated as low or very low certainty of evidence. Evidence on adverse events was collected by 7 of 13 (54%) reviews; serious adverse events attributed to massage therapy were not identified in those reviews, but adverse event data were often incomplete or inconsistently described. Conclusions: Only a small number of systematic reviews reported high- or moderate-certainty evidence supporting the potential benefit of massage therapy for specific non-painful adult health conditions. High-certainty evidence was limited to abdominal massage therapy for functional constipation, whereas moderate-certainty evidence indicated that acupressure and auricular acupressure may improve sleep quality in patients with cancer, acupressure may improve sleep latency and decrease fatigue in people with chronic kidney disease, and massage therapy may reduce depressive symptoms in individuals living with dementia. For most other non-painful adult health conditions evaluated, available conclusions are supported only by low- or very low-certainty evidence. Additional high-quality research is needed to strengthen the evidence base for massage therapy for non-painful adult health conditions, particularly for conditions and outcomes that currently lack at least moderate-certainty evidence.
- 20 August 2026
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 26 (1)
Open AccessUse of massage therapy for non-painful health conditions: an evidence map of systematic reviews
Background: There is high- or moderate-certainty evidence that massage therapy is beneficial for certain painful conditions. Massage therapy has also been evaluated for a range of non-painful health conditions, but the extent and certainty of this evidence are less well characterized. We mapped the systematic reviews, conclusions, and certainty (quality or strength) of evidence for outcomes of massage therapy for non-painful health conditions. Methods: Computerized search of PubMed, AMED, CINAHL, Cochrane Database of Systematic Reviews, and Web of Science from July 2018 to July 2024. This evidence map updates a Department of Veterans Affairs (VA) report that covered massage therapy reviews published through July 2018. Study selection included systematic reviews of massage therapy for non-painful adult health conditions that formally rated the certainty (quality or strength) of evidence supporting the conclusions. Systematic reviews of sports massage therapy, osteopathy, dry cupping/dry needling, and internal massage therapy (e.g., for pelvic floor pain), and self-administered massage therapy techniques (e.g., foam rolling) were ineligible. Main outcomes and measures include health condition, number of included studies, intervention, comparison group, conclusions, and certainty of evidence. Results: A total of 13 systematic reviews of massage therapy for 8 non-painful adult health conditions were identified. Of 190 full-text reviews, 20 used a formal method to rate the certainty (quality or strength) of evidence supporting their conclusions; 7 reviews overlapped in health condition, resulting in 13 included reviews. Across these, one conclusion about abdominal massage therapy for functional constipation was rated as high certainty of evidence. There were 4 conclusions from 3 reviews rated as moderate certainty of evidence: 2 conclusions in 1 review about acupressure and auricular acupressure for improving sleep quality in patients with cancer, 1 conclusion about acupressure for sleep latency and fatigue in people with chronic kidney disease, and 1 conclusion about massage improving depressive symptoms in individuals living with dementia; all remaining conclusions were rated as low or very low certainty of evidence. Evidence on adverse events was collected by 7 of 13 (54%) reviews; serious adverse events attributed to massage therapy were not identified in those reviews, but adverse event data were often incomplete or inconsistently described. Conclusions: Only a small number of systematic reviews reported high- or moderate-certainty evidence supporting the potential benefit of massage therapy for specific non-painful adult health conditions. High-certainty evidence was limited to abdominal massage therapy for functional constipation, whereas moderate-certainty evidence indicated that acupressure and auricular acupressure may improve sleep quality in patients with cancer, acupressure may improve sleep latency and decrease fatigue in people with chronic kidney disease, and massage therapy may reduce depressive symptoms in individuals living with dementia. For most other non-painful adult health conditions evaluated, available conclusions are supported only by low- or very low-certainty evidence. Additional high-quality research is needed to strengthen the evidence base for massage therapy for non-painful adult health conditions, particularly for conditions and outcomes that currently lack at least moderate-certainty evidence.
- 16 August 2026
- Published by SAGE Publications in Journal of Integrative and Complementary Medicine
An Evidence Map of Tai Chi and Qigong, 2014–2024: A Systematic Review
Introduction: The objective of this evidence map of systematic reviews was to identify and map systematic reviews published from 2014 to 2024 that evaluated Tai Chi or qigong for adult health conditions, summarize review conclusions, and abstract the reported certainty, quality, or strength of evidence. Methods: We searched Allied and Complementary Medicine Database, CINAHL, Cochrane Database of Systematic Reviews, Ovid MEDLINE, PsycINFO, and Scopus from January 2014 to March 2024. Eligible publications were systematic reviews of Tai Chi or qigong for adult health conditions that used a formal approach to assess certainty, quality, or strength of evidence and reported those ratings for the effect of Tai Chi or qigong . Four reviewers screened titles and abstracts in duplicate. Data on review characteristics, conclusions, and reported certainty assessments were extracted by one reviewer and verified by a second reviewer. Results: We included 26 systematic reviews. Two reviews reported high-certainty evidence for improved postmenopausal bone mineral density and reduced blood pressure in hypertension. Sixteen reviews reported at least one moderate-certainty conclusion. Eighteen of the 26 reviews reported adverse events data; among those 18 reviews, no serious adverse events were reported. Discussion: Among the included reviews, high-certainty evidence of benefit was reported for hypertension and postmenopausal bone mineral density. Several additional conditions had moderate-certainty conclusions, but much of the literature remained low or very low certainty. Safety interpretation was limited by inconsistent reporting of harms in the included reviews.
- 16 August 2026
- Published by SAGE Publications in Journal of Integrative and Complementary Medicine
An Evidence Map of Tai Chi and Qigong, 2014–2024: A Systematic Review
Introduction: The objective of this evidence map of systematic reviews was to identify and map systematic reviews published from 2014 to 2024 that evaluated Tai Chi or qigong for adult health conditions, summarize review conclusions, and abstract the reported certainty, quality, or strength of evidence. Methods: We searched Allied and Complementary Medicine Database, CINAHL, Cochrane Database of Systematic Reviews, Ovid MEDLINE, PsycINFO, and Scopus from January 2014 to March 2024. Eligible publications were systematic reviews of Tai Chi or qigong for adult health conditions that used a formal approach to assess certainty, quality, or strength of evidence and reported those ratings for the effect of Tai Chi or qigong . Four reviewers screened titles and abstracts in duplicate. Data on review characteristics, conclusions, and reported certainty assessments were extracted by one reviewer and verified by a second reviewer. Results: We included 26 systematic reviews. Two reviews reported high-certainty evidence for improved postmenopausal bone mineral density and reduced blood pressure in hypertension. Sixteen reviews reported at least one moderate-certainty conclusion. Eighteen of the 26 reviews reported adverse events data; among those 18 reviews, no serious adverse events were reported. Discussion: Among the included reviews, high-certainty evidence of benefit was reported for hypertension and postmenopausal bone mineral density. Several additional conditions had moderate-certainty conclusions, but much of the literature remained low or very low certainty. Safety interpretation was limited by inconsistent reporting of harms in the included reviews.
- Open Access
- 5 May 2026
- Published by Elsevier in Human Factors in Healthcare
- Vol. 9
Developing a human factors-informed onboarding workflow for digital health programs: lessons from a virtual type 2 diabetes self-management program
- 5 May 2026
- Published by Elsevier in Human Factors in Healthcare
- Vol. 9
Open AccessDeveloping a human factors-informed onboarding workflow for digital health programs: lessons from a virtual type 2 diabetes self-management program
- Open Access
- 21 March 2026
- Published by Elsevier in Human Factors in Healthcare
- Vol. 9
Directly engaging patients with glucose management: integrated visualization of personal device data for use between traditional visits
- 21 March 2026
- Published by Elsevier in Human Factors in Healthcare
- Vol. 9
Open AccessDirectly engaging patients with glucose management: integrated visualization of personal device data for use between traditional visits
- Open Access
- 20 March 2026
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 13 (1) , e82177
Deployment of an Activity Monitoring Program to Complement a Clinical Intervention for Veterans With Gulf War Illness: Qualitative Study
Background: Many veterans who served in the Gulf experience Gulf War Illness (GWI), a chronic multisymptom condition associated with fatigue, pain, gastrointestinal problems and respiratory issues, mood/cognitive issues, and sleep difficulties. These symptoms contribute to decreased function, increased mental health needs, and poor quality of life. The Veterans Affairs War Related Illness and Injury Study Center in New Jersey developed a 26-week virtual health coaching intervention to support symptom management for veterans with GWI. In 2023, a consumer-grade smartwatch was added as part of an activity monitoring program to complement this program. Objective: The purpose of this project was to assess the feasibility and acceptability of including a smartwatch-based activity monitoring component to complement a virtual health coaching program for veterans with GWI. Methods: Twenty-four veterans enrolled in the health coaching program were invited to participate in the activity monitoring component. Participants attended a virtual orientation to set up the smartwatch, and verbal consent to share data through a Health Insurance Portability and Accountability Act (HIPAA)-compliant platform was obtained. Program feasibility was assessed by evaluating wear-time percentage and duration of use. Acceptability was assessed using two items from a monthly survey and through a midprogram semistructured interview. Quantitative data were summarized descriptively, and qualitative data were analyzed using a coding scheme adapted from Sekhon et al’s Theoretical Framework for Acceptability (TFA). Results: Twenty veterans agreed to participate in the program (mean age 49 years; 7/20, 35% female; 19/20, 94% non-Hispanic White; 11/20, 55% first-time smartwatch users). Twelve participants (60%) wore the watch for the full 26 weeks. Among participants who completed 26 weeks, median daily wear-time completeness exceeded 80% for 25 weeks. Most participants (12/20, 60%) reported that wearing the smartwatch helped them achieve their wellness goals, and the majority (16/20, 80%) said they would recommend using the smartwatch for activity monitoring to other veterans. Qualitative findings supported acceptability across TFA domains. One adverse event was reported (minor skin irritation that resolved after changing the smartwatch band to a hypoallergenic watch band). Conclusions: Within this clinical program, pairing a smartwatch with virtual health coaching for veterans with GWI was feasible and acceptable. Activity monitoring integrated into an existing intervention may support symptom self-management and augment patient education and engagement. As no prior activity monitoring programs specific to veterans with GWI have been described, these findings could inform future program development and implementation within this population.
- 20 March 2026
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 13 (1) , e82177
Open AccessDeployment of an Activity Monitoring Program to Complement a Clinical Intervention for Veterans With Gulf War Illness: Qualitative Study
Background: Many veterans who served in the Gulf experience Gulf War Illness (GWI), a chronic multisymptom condition associated with fatigue, pain, gastrointestinal problems and respiratory issues, mood/cognitive issues, and sleep difficulties. These symptoms contribute to decreased function, increased mental health needs, and poor quality of life. The Veterans Affairs War Related Illness and Injury Study Center in New Jersey developed a 26-week virtual health coaching intervention to support symptom management for veterans with GWI. In 2023, a consumer-grade smartwatch was added as part of an activity monitoring program to complement this program. Objective: The purpose of this project was to assess the feasibility and acceptability of including a smartwatch-based activity monitoring component to complement a virtual health coaching program for veterans with GWI. Methods: Twenty-four veterans enrolled in the health coaching program were invited to participate in the activity monitoring component. Participants attended a virtual orientation to set up the smartwatch, and verbal consent to share data through a Health Insurance Portability and Accountability Act (HIPAA)-compliant platform was obtained. Program feasibility was assessed by evaluating wear-time percentage and duration of use. Acceptability was assessed using two items from a monthly survey and through a midprogram semistructured interview. Quantitative data were summarized descriptively, and qualitative data were analyzed using a coding scheme adapted from Sekhon et al’s Theoretical Framework for Acceptability (TFA). Results: Twenty veterans agreed to participate in the program (mean age 49 years; 7/20, 35% female; 19/20, 94% non-Hispanic White; 11/20, 55% first-time smartwatch users). Twelve participants (60%) wore the watch for the full 26 weeks. Among participants who completed 26 weeks, median daily wear-time completeness exceeded 80% for 25 weeks. Most participants (12/20, 60%) reported that wearing the smartwatch helped them achieve their wellness goals, and the majority (16/20, 80%) said they would recommend using the smartwatch for activity monitoring to other veterans. Qualitative findings supported acceptability across TFA domains. One adverse event was reported (minor skin irritation that resolved after changing the smartwatch band to a hypoallergenic watch band). Conclusions: Within this clinical program, pairing a smartwatch with virtual health coaching for veterans with GWI was feasible and acceptable. Activity monitoring integrated into an existing intervention may support symptom self-management and augment patient education and engagement. As no prior activity monitoring programs specific to veterans with GWI have been described, these findings could inform future program development and implementation within this population.
- 29 October 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (4)
Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial
Study Objectives: This pilot randomized trial measured the effects of a consumer-grade wearable-augmented program, which provides nightly pulse oximetry data to patients in a weekly report, on positive airway pressure (PAP) use in adults with obstructive sleep apnea (OSA) recruited from an outpatient sleep center. Methods: This single-blind, parallel, two-group waitlist-controlled, single-site randomized trial recruited individuals with OSA with insufficient PAP use from a Department of Veterans Affairs medical center and randomized them to immediate participation in the consumer wearable-augmented self-monitoring program versus waitlist. The primary outcome was the change in modem-measured PAP use (mean hours or minutes per night over a 7-day period) from baseline (T1) to T3 assessment, which was 35 days following randomization (7 days post-intervention for the immediate group and prior to intervention for the waitlist group). Results: We randomized 50 participants (mean age 47.9 years [SD 11.4]; 88% male). The change in PAP use was +1.33 hours (+79.8 minutes) for the immediate group and −0.17 hours (−10.2 minutes) for the waitlist control group, with a between-group difference of 1.50 hours (90 minutes) (p = .0097). The change in the number of days PAP was used for 4 hours or more over a 7-day period was +1.32 days for the immediate and 0.12 days for the waitlist control group, with a between-group difference of 1.20 (p = .0401). Conclusions: This pilot trial demonstrated that the consumer-grade wearable-augmented program is a promising intervention for increasing PAP use. A future full-scale trial that follows participants for a longer period is needed. Statement of Significance This pilot trial tested a novel use of the pulse oximetry feature available on some consumer-grade wearable devices to increase use of positive airway pressure (PAP) devices among adults with obstructive sleep apnea (OSA) and insufficient PAP use. The widespread and growing use of consumer-grade wearable devices offers an opportunity to leverage the features on these devices to tackle a common, problematic issue among individuals with OSA—insufficient use of PAP therapy. The randomized controlled design provides support for future research involving these devices.
- 29 October 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (4)
Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial
Study Objectives: This pilot randomized trial measured the effects of a consumer-grade wearable-augmented program, which provides nightly pulse oximetry data to patients in a weekly report, on positive airway pressure (PAP) use in adults with obstructive sleep apnea (OSA) recruited from an outpatient sleep center. Methods: This single-blind, parallel, two-group waitlist-controlled, single-site randomized trial recruited individuals with OSA with insufficient PAP use from a Department of Veterans Affairs medical center and randomized them to immediate participation in the consumer wearable-augmented self-monitoring program versus waitlist. The primary outcome was the change in modem-measured PAP use (mean hours or minutes per night over a 7-day period) from baseline (T1) to T3 assessment, which was 35 days following randomization (7 days post-intervention for the immediate group and prior to intervention for the waitlist group). Results: We randomized 50 participants (mean age 47.9 years [SD 11.4]; 88% male). The change in PAP use was +1.33 hours (+79.8 minutes) for the immediate group and −0.17 hours (−10.2 minutes) for the waitlist control group, with a between-group difference of 1.50 hours (90 minutes) (p = .0097). The change in the number of days PAP was used for 4 hours or more over a 7-day period was +1.32 days for the immediate and 0.12 days for the waitlist control group, with a between-group difference of 1.20 (p = .0401). Conclusions: This pilot trial demonstrated that the consumer-grade wearable-augmented program is a promising intervention for increasing PAP use. A future full-scale trial that follows participants for a longer period is needed. Statement of Significance This pilot trial tested a novel use of the pulse oximetry feature available on some consumer-grade wearable devices to increase use of positive airway pressure (PAP) devices among adults with obstructive sleep apnea (OSA) and insufficient PAP use. The widespread and growing use of consumer-grade wearable devices offers an opportunity to leverage the features on these devices to tackle a common, problematic issue among individuals with OSA—insufficient use of PAP therapy. The randomized controlled design provides support for future research involving these devices.
- Open Access
- 9 October 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (13) , 1-12
Integrating Consumer-Grade Wearable Devices and Patient-Generated Health Data into Clinical Care: Perspectives from Healthcare Professionals at a Learning Health System
Background: The increasing popularity of consumer-grade wearable (CGW) devices for everyday use has prompted discussions within learning healthcare systems (LHSs) about the integration of patient-generated health data (PGHD) into clinical workflow. Objective: To report findings from interviews with healthcare professionals (HCPs) about the potential role of CGWs and PGHD in clinical workflow, which in turn informed recommendations for health systems to consider when integrating PGHD from CGWs. Design: Mixed methods. Participants: Clinical care providers and holistic/wellness providers with various training and expertise from the largest integrated health system in the USA (i.e., Veterans Health Administration). Approach: A purposive sample of 29 individuals who were knowledgeable informants were invited to complete a survey focused on CGW feasibility and usability of PGHD. Those who completed the survey were invited to participate in a semi-structured interview to elicit their perceptions of the barriers and facilitators for PGHD utilization. Survey data were analyzed descriptively and rapid qualitative analysis techniques were used to identify themes from interview data. Key Results: Twenty-one HCPs were included in this study. Quantitative and qualitative findings revealed significant interest in PGHD integration in clinical workflow and patient interactions. Clinical care providers focused on the value of PGHD as a complement to traditional clinical data, whereas holistic/wellness providers emphasized using CGWs and PGHD for behavioral change. Their interest levels were tempered by concerns about workload implications and apprehension about having to distill the vast amount of PGHD of varying validity into clinically actionable information. Conclusions: Integrating CGWs and PGHD can enable an LHS to improve patient outcomes, particularly to promote health access and equity. Yet, concerns were raised regarding staffing and workload issues, data interpretation, expectations, access, privacy, and educational needs. Therefore, harnessing the benefits of CGWs will require investing in health systems’ infrastructure to optimally integrate PGHD into clinical workflow.
- 9 October 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 41 (13) , 1-12
Open AccessIntegrating Consumer-Grade Wearable Devices and Patient-Generated Health Data into Clinical Care: Perspectives from Healthcare Professionals at a Learning Health System
Background: The increasing popularity of consumer-grade wearable (CGW) devices for everyday use has prompted discussions within learning healthcare systems (LHSs) about the integration of patient-generated health data (PGHD) into clinical workflow. Objective: To report findings from interviews with healthcare professionals (HCPs) about the potential role of CGWs and PGHD in clinical workflow, which in turn informed recommendations for health systems to consider when integrating PGHD from CGWs. Design: Mixed methods. Participants: Clinical care providers and holistic/wellness providers with various training and expertise from the largest integrated health system in the USA (i.e., Veterans Health Administration). Approach: A purposive sample of 29 individuals who were knowledgeable informants were invited to complete a survey focused on CGW feasibility and usability of PGHD. Those who completed the survey were invited to participate in a semi-structured interview to elicit their perceptions of the barriers and facilitators for PGHD utilization. Survey data were analyzed descriptively and rapid qualitative analysis techniques were used to identify themes from interview data. Key Results: Twenty-one HCPs were included in this study. Quantitative and qualitative findings revealed significant interest in PGHD integration in clinical workflow and patient interactions. Clinical care providers focused on the value of PGHD as a complement to traditional clinical data, whereas holistic/wellness providers emphasized using CGWs and PGHD for behavioral change. Their interest levels were tempered by concerns about workload implications and apprehension about having to distill the vast amount of PGHD of varying validity into clinically actionable information. Conclusions: Integrating CGWs and PGHD can enable an LHS to improve patient outcomes, particularly to promote health access and equity. Yet, concerns were raised regarding staffing and workload issues, data interpretation, expectations, access, privacy, and educational needs. Therefore, harnessing the benefits of CGWs will require investing in health systems’ infrastructure to optimally integrate PGHD into clinical workflow.
- Open Access
- 10 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Deployment of an Activity Monitoring Program to Complement a Clinical Intervention for Veterans With Gulf War Illness: Qualitative Study (Preprint)
BACKGROUND Many veterans who served in the Gulf experience Gulf War Illness (GWI), a chronic multisymptom condition associated with fatigue, pain, gastrointestinal problems and respiratory issues, mood/cognitive issues, and sleep difficulties. These symptoms contribute to decreased function, increased mental health needs, and poor quality of life. The Veterans Affairs War Related Illness and Injury Study Center in New Jersey developed a 26-week virtual health coaching intervention to support symptom management for veterans with GWI. In 2023, a consumer-grade smartwatch was added as part of an activity monitoring program to complement this program. OBJECTIVE The purpose of this project was to assess the feasibility and acceptability of including a smartwatch-based activity monitoring component to complement a virtual health coaching program for veterans with GWI. METHODS Twenty-four veterans enrolled in the health coaching program were invited to participate in the activity monitoring component. Participants attended a virtual orientation to set up the smartwatch, and verbal consent to share data through a Health Insurance Portability and Accountability Act (HIPAA)-compliant platform was obtained. Program feasibility was assessed by evaluating wear-time percentage and duration of use. Acceptability was assessed using two items from a monthly survey and through a midprogram semistructured interview. Quantitative data were summarized descriptively, and qualitative data were analyzed using a coding scheme adapted from Sekhon et al’s Theoretical Framework for Acceptability (TFA). RESULTS Twenty veterans agreed to participate in the program (mean age 49 years; 7/20, 35% female; 19/20, 94% non-Hispanic White; 11/20, 55% first-time smartwatch users). Twelve participants (60%) wore the watch for the full 26 weeks. Among participants who completed 26 weeks, median daily wear-time completeness exceeded 80% for 25 weeks. Most participants (12/20, 60%) reported that wearing the smartwatch helped them achieve their wellness goals, and the majority (16/20, 80%) said they would recommend using the smartwatch for activity monitoring to other veterans. Qualitative findings supported acceptability across TFA domains. One adverse event was reported (minor skin irritation that resolved after changing the smartwatch band to a hypoallergenic watch band). CONCLUSIONS Within this clinical program, pairing a smartwatch with virtual health coaching for veterans with GWI was feasible and acceptable. Activity monitoring integrated into an existing intervention may support symptom self-management and augment patient education and engagement. As no prior activity monitoring programs specific to veterans with GWI have been described, these findings could inform future program development and implementation within this population.
- 10 August 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDeployment of an Activity Monitoring Program to Complement a Clinical Intervention for Veterans With Gulf War Illness: Qualitative Study (Preprint)
BACKGROUND Many veterans who served in the Gulf experience Gulf War Illness (GWI), a chronic multisymptom condition associated with fatigue, pain, gastrointestinal problems and respiratory issues, mood/cognitive issues, and sleep difficulties. These symptoms contribute to decreased function, increased mental health needs, and poor quality of life. The Veterans Affairs War Related Illness and Injury Study Center in New Jersey developed a 26-week virtual health coaching intervention to support symptom management for veterans with GWI. In 2023, a consumer-grade smartwatch was added as part of an activity monitoring program to complement this program. OBJECTIVE The purpose of this project was to assess the feasibility and acceptability of including a smartwatch-based activity monitoring component to complement a virtual health coaching program for veterans with GWI. METHODS Twenty-four veterans enrolled in the health coaching program were invited to participate in the activity monitoring component. Participants attended a virtual orientation to set up the smartwatch, and verbal consent to share data through a Health Insurance Portability and Accountability Act (HIPAA)-compliant platform was obtained. Program feasibility was assessed by evaluating wear-time percentage and duration of use. Acceptability was assessed using two items from a monthly survey and through a midprogram semistructured interview. Quantitative data were summarized descriptively, and qualitative data were analyzed using a coding scheme adapted from Sekhon et al’s Theoretical Framework for Acceptability (TFA). RESULTS Twenty veterans agreed to participate in the program (mean age 49 years; 7/20, 35% female; 19/20, 94% non-Hispanic White; 11/20, 55% first-time smartwatch users). Twelve participants (60%) wore the watch for the full 26 weeks. Among participants who completed 26 weeks, median daily wear-time completeness exceeded 80% for 25 weeks. Most participants (12/20, 60%) reported that wearing the smartwatch helped them achieve their wellness goals, and the majority (16/20, 80%) said they would recommend using the smartwatch for activity monitoring to other veterans. Qualitative findings supported acceptability across TFA domains. One adverse event was reported (minor skin irritation that resolved after changing the smartwatch band to a hypoallergenic watch band). CONCLUSIONS Within this clinical program, pairing a smartwatch with virtual health coaching for veterans with GWI was feasible and acceptable. Activity monitoring integrated into an existing intervention may support symptom self-management and augment patient education and engagement. As no prior activity monitoring programs specific to veterans with GWI have been described, these findings could inform future program development and implementation within this population.